Author

Brooke Byrd

Institution: CVS Health (United States)

Observed institution: CVS Health (United States)

ORCID: 0009-0003-6253-8420

Observed ORCID: 0009-0003-6253-8420

OpenAlex ID: A5073739609

Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models

2024 · Lalan Wilfong, Lauren Baggett, et al. · JCO Oncology Practice · 2

Adherence to abemaciclib in patients receiving antidiarrheal medicine.

2021 · Dipti Shah, Brooke Byrd, et al. · Journal of Clinical Oncology · 1

National Comprehensive Cancer Network guideline compliance in an oncology value-based care program serving Medicare members.

2025 · Shirisha Reddy, Anthony Larrarte, et al. · Journal of Clinical Oncology

National Comprehensive Cancer Network guideline compliance in an oncology value-based care program serving Medicare members.

2024 · Edward Thompson, Kevin Hastings, et al. · Journal of Clinical Oncology

Influence of sociodemographic factors on time to diagnosis and treatment among members of a large national payor diagnosed with lung cancer.

2024 · Shirisha Reddy, Brooke Byrd, et al. · Journal of Clinical Oncology

Influence of health insurance type on time to breast cancer diagnosis and treatment among members of a large national payor.

2024 · Shirisha Reddy, Brooke Byrd, et al. · Journal of Clinical Oncology

Using real-world evidence to evaluate broad panel vs. sequential single and narrow panel sequencing in members with non-small cell lung cancer (NSCLC).

2023 · Brooke Byrd, Alexa Hospodar, et al. · Journal of Clinical Oncology

Economic impact of broad panel versus sequential single and narrow panel sequencing in lung cancer patients.

2022 · Alexa Hospodar, Brooke Byrd, et al. · Journal of Clinical Oncology

Works count: 8

Citation count: 3

H-index: 1

I10-index: